Redundancy of age restrictions for MM treatment
Autologous stem cell transplantation (ASCT) for multiple myeloma (MM) patients has often been capped at 65 years of age. However, Mohamad Mohty, MD, PhD, of the University Pierre & Marie Curie, Pa...
Author: VJHemOnc
Added: 07/25/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts